TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
ALBUQUERQUE, N.M., April 26, 2016 -- TriCore Reference Laboratories' Chief Information Officer, Bill Baker, will address the audience at the Executive War College meeting on Tuesday, April 26, 2016.
Mr. Baker will explain how TriCore's early successes at advancing clinical care and improving patient outcomes will enrich clinical intelligence. TriCore is reshaping the way medicine is delivered through laboratory-driven population health management. Selecting the right test at the right time and converting the resulting data to actionable information, TriCore is helping to reduce the total cost of care and improve patient outcomes.
TriCore generates more than 70% of New Mexico's clinical test data. Combining years of longitudinal and chronological data with analytics powered by Rhodes technology, TriCore connects data from different providers and identifies geographic patterns.
"It is an exciting area for healthcare from clinical, technology and economic perspectives. Using advanced laboratory data analytics we can track patient care, outcomes, and the cost of care. This information adds value for physicians, patients, and payers by helping close gaps, improve outcomes, as well as reduce the cost of care," said Bill Baker, CIO of TriCore Reference Laboratories.
"Technology and integration of clinical lab data with predictive and actionable values create a unique business model. This new model focuses on our value proposition by bringing real data, performing population risk stratification, reducing the effect of latency and developing high risk targeted interventions" says Khosrow Shotorbani, CEO of TriCore Reference Laboratories. "Together with Rhodes, we are advancing analytics to drive improvements in patient and population health through targeted intervention to positively affect patient lives".
About TriCore
Founded in 1998 and headquartered in Albuquerque, New Mexico, TriCore Reference Laboratories is an independent, clinical reference laboratory that provides full-service, state of the art laboratory tests to health care professionals and their patients. TriCore offers more than 1,700 laboratory tests ranging from routine to highly specialized. TriCore participates in scientific research through collaboration with the University of New Mexico and numerous national and international biotech firms. TriCore is a CAP ISO 15189SM certified medical laboratory.
CONTACT: Media Contact:
Carol P Biondi
505-379-5616
[email protected]
